Melanoma susceptibility and progression: Association study between polymorphisms of the chemokine (CCL2) and chemokine receptors (CX3CR1, CCR5)

Journal of Dermatological Science

Volumn 46, Issue 1, 2007, Pages 72-76

  Rodero, Mathieu ^a   Rodero, Pauline ^a   Descamps, Vincent ^b   Aegerter, Philippe ^c   Vitoux, Dominique ^d   Lebbe, Céleste ^d   Wolkenstein, Pierre ^e   Basset Seguin, Nicole ^d   Dupin, Nicolas ^e   Grandchamp, Bernard ^b   Soufir, Nadem ^b   Saiag, Philippe ^c   Combadière, Christophe ^a  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e HENRI MONDOR HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR1; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; FRANCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INNATE IMMUNITY; LETTER; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; RISK FACTOR; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHEMOKINE CCL2; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MELANOMA; MIDDLE AGED; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RISK FACTORS; SKIN NEOPLASMS;

EID: 33847774263     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.11.007     Document Type: Letter

References (10)

1. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 4 7 (2004) 540-550
2. Hussein M.R. Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight. Br J Dermatol 153 1 (2005) 18-21
3. Ghilardi G., Biondi M.L., La Torre A., Battaglioli L., and Scorza R. Breast cancer progression and host polymorphisms in the chemokine system: role of the macrophage chemoattractant protein-1 (MCP-1)-2518 G allele. Clin Chem 51 2 (2005) 452-455
4. Lavergne E., Labreuche J., Daoudi M., Debre P., Cambien F., Deterre P., Amarenco P., and Combadiere C. Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler Thromb Vasc Biol 25 4 (2005) 847-853
5. Breslow A. Tumor thickness in evaluating prognosis of cutaneous melanoma. Ann Surg 187 4 (1978) 440
6. Muhlbauer M., Ringel S., Hartmann A., et al. Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma. Oncol Rep 13 5 (2005) 957-963
7. Zafiropoulos A., Crikas N., Passam A.M., and Spandidos D.A. Significant involvement of CCR2-64I and CXCL12-3a in the development of sporadic breast cancer. J Med Genet 41 5 (2004) e59
8. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 2 (1999) 344-348
9. Mantovani A., Bottazzi B., Colotta F., Sozzani S., and Ruco L. The origin and function of tumor-associated macrophages. Immunol Today 13 7 (1992) 265-270
10. Lewis C.E., and Pollard J.W. Distinct role of macrophages in different tumor microenvironments. Cancer Res 66 2 (2006) 605-612